Through the partnership, Zephyr will train its Insights predictive analysis tool with MedStar’s datasets. Initially, the partnership will focus on Type 2 diabetes, according to a Nov. 4 Zephyr news release.
“We are laser-focused on delivering results that improve the timeliness of Type 2 diabetes interventions and decrease devastating adverse health outcomes commonly associated with the chronic condition, such as end-stage chronic kidney disease, dialysis, foot ulcers, and amputations,” Zephyr co-founder and Chair Grant Verstandig said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
